Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

被引：0
|
作者：
Orly Vardeny
James C. Fang
Akshay S. Desai
Pardeep S. Jhund
Brian Claggett
Muthiah Vaduganathan
Rudolf A. de Boer
Adrian F. Hernandez
Carolyn S. P. Lam
Silvio E. Inzucchi
Felipe A. Martinez
Mikhail N. Kosiborod
David DeMets
Eileen O’Meara
Shelley Zieroth
Josep Comin-Colet
Jaroslaw Drozdz
Chern-En Chiang
Masafumi Kitakaze
Magnus Petersson
Daniel Lindholm
Anna Maria Langkilde
John J. V. McMurray
Scott D. Solomon
机构：
[1] University of Minnesota,Minneapolis VA Center for Care Delivery and Outcomes Research
[2] University of Utah Medical Center,BHF Glasgow Cardiovascular Research Center, School of Cardiovascular and Metabolic Health
[3] Cardiovascular Division, Department of Cardiology, Thoraxcenter
[4] Brigham and Women’s Hospital,Cardiology Department
[5] Harvard Medical School,Department Cardiology
[6] University of Glasgow,General Clinical Research Center and Division of Cardiology
[7] Erasmus Medical Center,undefined
[8] Duke University Medical Center,undefined
[9] National Heart Centre Singapore and Duke–National University of Singapore,undefined
[10] Yale School of Medicine,undefined
[11] Universidad Nacional de Córdoba,undefined
[12] Saint Luke’s Mid America Heart Institute and University of Missouri-Kansas City,undefined
[13] University of Wisconsin,undefined
[14] Montreal Heart Institute and Université de Montréal,undefined
[15] St. Boniface Hospital & University of Manitoba,undefined
[16] Bellvitge University Hospital,undefined
[17] Bio-Heart Bellvitge Institute for Biomedical Research,undefined
[18] University of Barcelona,undefined
[19] Hospitalet de Llobregat,undefined
[20] Medical University Lodz,undefined
[21] Taipei Veterans General Hospital and National Yang Ming Chiao Tung University,undefined
[22] Kinshukai Hanwa Daini Senboku Hospital,undefined
[23] Late-Stage Development,undefined
[24] Cardiovascular,undefined
[25] Renal,undefined
[26] and Metabolism,undefined
[27] BioPharmaceuticals R&D,undefined
[28] AstraZeneca,undefined
来源：
Nature Medicine | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3269 / 3269
相关论文
共 50 条
  • [41] Letter by Wong and Demers Regarding Article, "Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial"
    Wong, Eric K. C.
    Demers, Catherine
    CIRCULATION, 2023, 147 (14) : 1118 - 1118
  • [42] Dapagliflozin reduces loop diuretic requirement over time in patients with heart failure with mildly reduced or preserved ejection fraction in the DELIVER Trial
    Chatur, Safia
    Vaduganathan, M.
    Claggett, B.
    Vardeny, O.
    Desai, A. S.
    Jhund, P. S.
    De Boer, R. A.
    Lam, C. S. P.
    Kosiborod, M. N.
    Shah, S. J.
    Martinez, F.
    Inzucchi, S. E.
    Hernandez, A. F.
    Mc Murray, J. J. V.
    Solomon, S. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 39 - 40
  • [43] Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
    Solomon, S. D.
    McMurray, J. J., V
    Claggett, B.
    de Boer, R. A.
    DeMets, D.
    Hernandez, A. F.
    Inzucchi, S. E.
    Kosiborod, M. N.
    Lam, C. S. P.
    Martinez, F.
    Shah, S. J.
    Desai, A. S.
    Jhund, P. S.
    Belohlavek, J.
    Chiang, C-E
    Borleffs, C. J. W.
    Comin-Colet, J.
    Dobreanu, D.
    Drozdz, J.
    Fang, J. C.
    Alcocer-Gamba, M. A.
    Al Habeeb, W.
    Han, Y.
    Cabrera Honorio, J. W.
    Janssens, S. P.
    Katova, T.
    Kitakaze, M.
    Merkely, B.
    O'Meara, E.
    Saraiva, J. F. K.
    Tereshchenko, S. N.
    Thierer, J.
    Vaduganathan, M.
    Vardeny, O.
    Verma, S.
    Pham, V. N.
    Wilderang, U.
    Zaozerska, N.
    Bachus, E.
    Lindholm, D.
    Petersson, M.
    Langkilde, A. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, : 1089 - 1098
  • [44] Effect of dapagliflozin in patients in Asia with heart failure with mildly reduced or preserved ejection fraction: insights from DELIVER
    Wang, X.
    Lam, C. S. P.
    Claggett, B.
    Miao, M.
    Shah, S. J.
    Jhund, P. S.
    Desai, A. S.
    Chiang, C.
    Pham, V. N.
    Han, Y.
    Kitakaze, M.
    Langkilde, A. M.
    Mcmurray, J. J. V.
    Solomon, S. D.
    Vaduganathan, M.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [45] Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
    Blair, Hannah A.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (06) : 701 - 710
  • [46] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction REPLY
    McMurray, John J. V.
    Docherty, Kieran F.
    Jhund, Pardeep S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (10): : 973 - 973
  • [47] Dapagliflozin in Heart Failure with Preserved Ejection Fraction-Reply
    Kjaergaard, Jesper
    Moller, Jacob E.
    Hassager, Christian
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (03): : 285 - 286
  • [48] Efficacy of Dapagliflozin in Heart Failure with Preserved Ejection Fraction in the Elderly
    Bu, X. P.
    Li, C. X.
    Li, L.
    Liu, Y. R.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 : S24 - S24
  • [49] Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
    Hannah A. Blair
    American Journal of Cardiovascular Drugs, 2021, 21 : 701 - 710
  • [50] Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial
    Docherty, Kieran F.
    Henderson, Alasdair D.
    Jhund, Pardeep S.
    Claggett, Brian L.
    Desai, Akshay S.
    Mueller, Katharina
    Viswanathan, Prabhakar
    Scalise, Andrea
    Lam, Carolyn S. P.
    Senni, Michele
    Shah, Sanjiv J.
    Voors, Adriaan A.
    Zannad, Faiez
    Pitt, Bertram
    Vaduganathan, Muthiah
    Solomon, Scott D.
    Mcmurray, John J. V.
    CIRCULATION, 2025, 151 (01) : 45 - 58
12345